SCHMERTZLER MICHAEL bought PTCT
December 16, 2025 · Form 4 insider transaction
SCHMERTZLER MICHAEL bought 24,000 shares of PTC Therapeutics, Inc. at $30.86 per share, a transaction worth $740.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
24,000
Price
$30.86
Total value
$740.6K
InsiderSCHMERTZLER MICHAEL
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 16, 2025
Filing dateDecember 18, 2025
Shares owned after155,266
OwnershipDirect
10b5-1 planNo
AmendedNo